What is the main business of Plus Pharmaceuticals?

The main business activity of Plus Pharmaceuticals focuses on market research and public opinion polling.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 7, 2023.

Where is the headquarters located?

The headquarters is located at: Szafranowa 6, 21-003 Elizówka.

Who is on the management board?

The management board includes Mariusz Tomasz Trus (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

In 2024, the company generated total revenue of $765,949, representing an increase of 272.3% compared to 2023.

Yes, the company recorded a net profit of $20,082 in 2024, representing a multi-fold increase compared to 2023.

What is the largest operating cost?

The largest operating cost category falls under employee remuneration. This category amounted to $549,456 in 2024, representing 74% of all operating expenses.

Plus Pharmaceuticalssp. z o.o.

Market research and public opinion polling

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2023-06-07

Share capital

5,000.00 PLN

Registered address

Szafranowa 6, 21-003 Elizówka, Poland

Electronic delivery address

AE:PL-78542-63535-VGCUF-29

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 4 days early.

202513/07/2026
202411/07/2025
202309/07/2024

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 824.82kMedianUSD 112.93kAverageUSD 1.39m

Net profit

This companyUSD 18.28kMedianUSD 3.36kAverageUSD 117.95k

Operating costs

This companyUSD 800.18kMedianUSD 100.06kAverageUSD 1.26m

Assets

This companyUSD 228.93kMedianUSD 92.09kAverageUSD 1.28m

Industry

Market research and public opinion polling (73.20.Z)Primary

Authorized Representatives

Katarzyna Lidia Grosner – Attorney-in-fact

Mariusz Tomasz Trus – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Solpharma Plus sp. z o.o.	50	$1,350.62	100%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2023-07-12.

ING Bank Śląski
74 1050 1953 1000 0090 3296 8639
ING Bank Śląski
75 1050 1953 1000 0090 3296 8621

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
BD Centersp. z o.o.	$1,153,860.93	bdcenter.pl
Flow Centrum Badawczesp. z o.o.	$983,607.26	makeitflow.pl
Grupa Bstsp. z o.o.	$928,763.71	grupabst.pl
Openfieldsp. z o.o.	$709,346.30	openfield.pl
Tgthsp. z o.o.	$690,714.96	tgth.pl
Maison & Partnerssp. z o.o.	$554,241.32	maison.pl
Cxstreamsp. z o.o.	$546,554.22	cxstream.pl
Sigmacem Analytics IIsp. z o.o.	$466,007.65	opinello.com
Unique Managementsp. z o.o.	$433,333.37	uniqueagency.pl
Biuro Badań Społecznych Question Marksp. z o.o.	$445,109.88	questionmark.pl